BNP Paribas Financial Markets
PPBT

BNP Paribas Financial Markets’s Purple Biotech PPBT Stock Holding History

BNP Paribas Financial Markets’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.91K Sell
1,957
-151
-7% -$815 ﹤0.01% 5256
2025
Q4 		$13.9K Buy
2,108
+980
+87% +$7.11K ﹤0.01% 5103
2025
Q3 		$6.47K Buy
1,128
+500
+80% +$8.97K ﹤0.01% 5070
2025
Q2 		$14.7K Buy
628
+90
+17% +$2.23K ﹤0.01% 4727
2025
Q1 		$14.3K Hold
538
– – ﹤0.01% 4625
2024
Q4 		$25.2K Buy
538
+170
+46% +$6.54K ﹤0.01% 4662
2024
Q3 		$20.4K Buy
+368
New +$27.8K ﹤0.01% 3745

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

BNP Paribas Financial Markets's PPBT Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Purple Biotech (PPBT) stake by 7.2% in Q1 2026, selling an estimated $815 and leaving 1,957 shares worth $7.91K. The position accounts for ﹤0.01% of the portfolio, ranked #5256.

BNP Paribas Financial Markets first reported a position in PPBT in Q3 2024 and has held it in 7 quarters since. The position peaked at $25.2K in Q4 2024. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • BNP Paribas Financial Markets held 1,957 shares of Purple Biotech worth $7.91K as of Q1 2026.
  • BNP Paribas Financial Markets sold 151 Purple Biotech shares in Q1 2026, an estimated $815.
  • Purple Biotech made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5256 holding.
  • BNP Paribas Financial Markets first reported a position in Purple Biotech in Q3 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Purple Biotech position peaked at $25.2K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.